Evidence map›Paper›PMID 35157510›Full record

ReviewJCO global oncology2022

Mapping Pediatric Oncology Clinical Trial Collaborative Groups on the Global Stage.

Ajay Major, Monica Palese, Ebru Ermis, Anthony James, Milena Villarroel, Federico Antillon Klussmann, Laila Hessissen, Jennifer Geel, Muhammad Saghir Khan, Rashmi Dalvi and 7 more

Abstract readReview
In one paragraph

Review in JCO global oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Building a transdisciplinary network to improve survival in children with cancer in Colombia: seeds to forests.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Ajay MajorDepartment of Medicine, Section of Hematology/Oncology, University of Chicago, Chicago, IL.ORCID 0000-0001-7261-1335
Monica PaleseDepartment of Pediatrics, University of Chicago, Chicago, IL.
Ebru ErmisDepartment of Pediatrics, University of Chicago, Chicago, IL.
Anthony JamesDepartment of Pediatrics, University of Chicago, Chicago, IL.
Milena VillarroelGrupo de América Latina de Oncología Pediátrica (GALOP), Hospital Luis Calvo Mackenna, National Pediatric Cancer Program (PINDA), Santiago, Chile.
Federico Antillon KlussmannNational Unit of Pediatric Oncology, Francisco Marroquin University School of Medicine, Guatemala City, Guatemala.
Laila HessissenPediatric Hematology and Oncology, Mohammed V University of Rabat, Rabat, Morocco.ORCID 0000-0002-3322-273X
Jennifer GeelFaculty of Health Sciences, Division of Pediatric Haematology and Oncology, Department of Pediatrics and Child Health, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, South Africa.ORCID 0000-0001-8792-3251
Muhammad Saghir KhanDepartment of Pediatrics, King Faisal Specialist Hospital and Research Center, Al Madinah, Saudi Arabia.ORCID 0000-0003-4213-275X
Rashmi DalviBombay Hospital Institute of Medical Sciences and SRCC Children's Hospital, Mumbai, India.ORCID 0000-0002-8883-7088
Michael SullivanChildren's Cancer Centre, Royal Children's Hospital, Melbourne, Australia.ORCID 0000-0002-8606-5889
Pamela KearnsCancer Research UK Clinical Trials Unit, National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre, Institute of Cancer and Genomic Sciences, Birmingham, United Kingdom.ORCID 0000-0003-2756-5813
A Lindsay FrazierDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-4748-8552
Kathy Pritchard-JonesUCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Akira NakagawaraIon Beam Therapy Center, SAGA HIMAT Foundation, Saga, Japan.
Carlos Rodriguez-GalindoDepartment of Global Pediatric Medicine, St Jude Children's Research Hospital, Memphis, TN.ORCID 0000-0002-2360-8946
Samuel L VolchenboumDepartment of Pediatrics, University of Chicago, Chicago, IL.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe global pediatric oncology clinical research landscape, particularly in Central and South America, Africa, and Asia, which bear the highest burden of global childhood cancer cases, is less characterized in the literature. Review of how existing pediatric cancer clinical trial groups internationally have been formed and how their research goals have been pursued is critical for building global collaborative research and data-sharing efforts, in line with the WHO Global Initiative for Childhood Cancer.

methodsA narrative literature review of collaborative groups performing pediatric cancer clinical research in each continent was conducted. An inventory of research groups was assembled and reviewed by current pediatric cancer regional and continental leaders. Each group was narratively described with identification of common structural and research themes among consortia.

resultsThere is wide variability in the structure, history, and goals of pediatric cancer clinical trial collaborative groups internationally. Several continental regions have longstanding endogenously-formed clinical trial groups that have developed and published numerous adapted treatment regimens to improve outcomes, whereas other regions have consortia focused on developing foundational database registry infrastructure supported by large multinational organizations or twinning relationships.

conclusionThere cannot be a one-size-fits-all approach to increasing collaboration between international pediatric cancer clinical trial groups, as this requires a nuanced understanding of local stakeholders and resources necessary to form partnerships. Needs assessments, performed either by local consortia or in conjunction with international partners, have generated productive clinical trial infrastructure. To achieve the goals of the Global Initiative for Childhood Cancer, global partnerships must be sufficiently granular to account for the distinct needs of each collaborating group and should incorporate grassroots approaches, robust twinning relationships, and implementation science.

Indexed as

Medical OncologyNeoplasmsAfricaChildDatabases, FactualHumansInformation Dissemination

Identifiers

PMID35157510
PMCPMC8853619

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.